Brillantes, Rosalie .

HRN: 29-10-63  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/08/2026
CEFUROXIME 500MG (TAB)
07/08/2026
07/15/2026
PO
500
Bid
Uti
Checking Initial Appropriateness 

 Indication:  ProphylaxisEmpiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines